DASH Diet, Quality of Life and Cardiac Parameters of Patients With Acute Coronary Syndrome

NCT ID: NCT06485765

Last Updated: 2024-07-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

34 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-06-01

Study Completion Date

2021-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The clinical trail study aimed to determine effect of DASH eating plan on cardiac parameters and quality of life in hypertensive individuals diagnosed with acute coronary syndrome.

The main questions it aims to answer are:

1. DASH diet improve quality of life?
2. DASH diet improve cardiac parameters?

The researchers assessed the results of 12 weeks of the DASH diet.

Patients will apply the DASH diet prepared individually by the researchers for 12 weeks.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study period was 12 weeks. Patients' food consumption (3 day), anthropometric measurements, blood pressure measurements, physical activity levels, biochemical and cardiac parameters, adherence to DASH eating plan and the MacNew Heart Health-Related Quality of Life Scale were recorded at the beginning of the study and at the end of 12 weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Coronary Syndrome Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

This clinical trial is a single-group, pre-post design. In this model, quality of life and cardiac parameters were assessed before and after individualised DASH diet.
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group

The daily energy requirement of the individuals included in the study was obtained by multiplying the physical activity level (PAL) calculated as a result of 24-hour physical activity recording and the Harris-Benedict formula used to calculate the basal metabolic rate.

Harris-Benedict Formula Male 66.5 + 13.75 x Weight (kg) + 5.003 x Height (cm) - 6.775 x Age (years) Female 655.1 + 9.563 x Weight (kg) + 1.85 x Height (cm) - 4.676 x Age (years)

After the daily energy requirement was calculated, a DASH eating plan specific to the individuals was created and they were asked to maintain it for 12 weeks. In addition, the personal contact information of the researcher was shared with the individuals and they were in constant communication about all questions related to the nutrition plan.

Group Type EXPERIMENTAL

Diet planning

Intervention Type OTHER

Healthy eating planning

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Diet planning

Healthy eating planning

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* diagnosed with acute coronary syndrome within the last month
* with a measured blood pressure above 140/90 mmHg or using antihypertensive drugs
* not obese (body mass index \< 30)
* not diagnosed with a disease requiring a different medical nutrition therapy (chronic renal failure, diabetes, cancer, etc.)
* volunteered to participate in the study

Exclusion Criteria

* Acute coronary syndrome diagnosed more than 1 month ago
* obese (body mass index \> 30 )
* without hypertension
* receiving different medical nutrition therapy
Minimum Eligible Age

19 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bandırma Onyedi Eylül University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hacı Ömer YILMAZ

Assistant Professor (PhD)

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bandırma Onyedi Eylul University

Balıkesir, Bandırma, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

hcmrylmz-2024

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effects of Curcumin on Vascular Reactivity
NCT01543386 COMPLETED PHASE1/PHASE2
Diet and Vascular Health Study
NCT01114399 COMPLETED NA